Onconova Implementation Guide
0.2.0 - ci-build

Onconova Implementation Guide - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Terminology

Value Sets

The following value sets have been defined for this implementation guide:

  • TNM Lymphatic Invasion Categories Value Set

    TNM Lymphatic Invasion Categories Value Set

  • TNM Perineural Invasion Categories Value Set

    TNM Perineural Invasion Categories Value Set

  • TNM Residual Tumor Categories Value Set

    TNM Residual Tumor Categories Value Set

  • Adjunctive Therapy Roles Value Set

    Codes representing roles for adjunctive therapy in oncology.

  • Adverse Event Mitigation Categories Value Set

    Categories of actions taken to mitigate or manage adverse events in oncology.

  • Adverse Event Mitigation Drugs Value Set

    Drugs or medication categories used in the mitigation process of an adverse event.

  • Adverse Event Mitigation Managements Value Set

    Classification of actions to mitigate adverse events affecting a patient's health.

  • Adverse Event Mitigation Procedures Value Set

    Procedures undertaken to mitigate the impact of an adverse event on a patient's health.

  • Adverse Event Mitigation Treatment Adjustments Value Set

    Adjustments made to a patient's treatment plan in response to an adverse event.

  • Amino Acid Change Type Value Set

    Amino acid change types due to a genomic variant. It constraints and expands the original LOINC Answer List LL380-7 to enforce Onconova-compatible codes

  • Antineoplastic Agents Value Set

    Drugs and biological agents used in the treatment of neoplastic diseases.

  • Cancer Imaging Methods Value Set

    Imaging methods used in cancer diagnosis and monitoring.

  • Cancer Risk Assessment Methods Value Set

    A value set containing codes for various cancer risk assessment methods.

  • Risk Assessment Values Value Set

    A non-exhaustive value set containing codes that result from risk assessments, i.e., the risk level of the cancer.

  • Cause of Death Value Set

    The causes of death that are relevant for a cancer patient.

  • Clinical Relevance Value Set

    Categorizations of the clinical relevance of a genomic variant

  • Comorbidity Panels Value Set

    A collection of comorbidity panels relevant to cancer patients.

  • Consent Status Value Set

    The consent status of a patient for further use of data in research.

  • CTC Adverse Events Value Set

    Adverse events classified according to the Common Terminology Criteria for Adverse Events (CTCAE)

  • Coding DNA Change Types Value Set

    Coding DNA change types due to a genomic variant. It constraints and expands the original LOINC Answer List LL380-7 to enforce Onconova-compatible codes

  • Expected Drug Effects Value Set

    Collection of expected effects when a drug is administered.

  • Exposure Agents Value Set

    Agents to which a patient may have been exposed.

  • Homologous Recombination Deficiency Interpretation Value Set

    The categorical classifications of the HRD status interpreted from its value..

  • ICD-10 Codes Value Set

    All possible ICD-10 codes for conditions.

  • ICD-O-3 Differentiations Value Set

    The subset of ICD-O-3 concepts dedicated for describing morphology differentiations.

  • ICD-O-3 Morphology Behavior Value Set

    The subset of ICD-O-3 concepts dedicated for describing morphology behavior.

  • ICD-O-3 Topographies Value Set

    The subset of ICD-O-3 concepts dedicated for describing morphology topographies.

  • Observation Body Sites Value Set

    Bodysites related to an observation

  • Recreational Drugs Value Set

    Substances that people use to alter their mental state, often for pleasure or leisure, with effects ranging from relaxation and euphoria to hallucinations and altered perceptions.

  • Recurrence Types Value Set

    A value set representing the types of cancer recurrence, specifically local and regional recurrences.

  • Smoking status Value Set

    Smoking status of a patient

  • Surgical Procedures Value Set

    Set of surgical procedures relevant to cancer treatment in Onconova.

  • TNM Distant Metastasis Categories Value Set

    TNM Distant Metastasis Categories Value Set

  • TNM Grade Categories Value Set

    TNM Grade Categories Value Set

  • TNM Grade Category Methods Value Set

    TNM Grade Category Methods Value Set

  • TNM Primary Tumor Categories Value Set

    TNM Primary Tumor Categories Value Set

  • TNM Regional Nodes Categories Value Set

    TNM Regional Nodes Categories Value Set

  • TNM Serum Tumor Marker Level Categories Value Set

    TNM Serum Tumor Marker Level Categories Value Set

  • TNM Venous Invasion Categories Value Set

    TNM Venous Invasion Categories Value Set

  • Treatment Intents Value Set

    A set of intents for giving a treatment to a cancer patient

  • Treatment Termination Reasons Value Set

    Reasons for terminating a treatment in oncology.

  • Tumor Board Recommendations Value Set

    Recommendations that may be made by a tumor board for a cancer patient.

  • Tumor Marker Analytes Value Set

    Analytes considered tumor markers.

  • Tumor Marker Tests

    ValueSet containing LOINC and NCI Thesaurus codes for tumor marker laboratory tests and measurements

  • Tumor Mutational Burden Status Interpretation Value Set

    The categorical classifications of the TMB status interpreted from its value..

  • Vital Status Value Set

    The vital status of a patient

  • Code Systems

    The following code systems have been defined for this implementation guide:

  • Comorbidity Panels Code System

    A code system for comorbidity panels relevant to cancer patients.

  • Consent Status Code System

    A code system for consent status relevant to Onconova patients.

  • To Be Determined Codes

    A code system for codes that are yet to be determined.